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Abstract
Background Binge eating episodes characterized by loss of
control are hypothesized to be accompanied by changes in
hypothalamic pituitary adrenal (HPA) axis functioning.
Cortisol is an end product of this neuroendocrine stress
system.
Purpose The aim of this study was to examine the cortisol
levels and the awakening cortisol response (ACR) in obese
persons showing binge eating after surgery for morbid
obesity.
Method Sixteen obese women with binge eating disorder
(BED) and 18 obese women without BED participated in
the study. Means±SD: age 43±15, body mass index 40±8.
Salivary cortisol, anthropometric assessments, and the
eating disorder examination interview were taken.
Results Women with BED showed a significantly lower
waist-to-hip ratio and cortisol levels during the day than
women without BED, whereas the ACR did not differ.
Conclusion Our cross-sectional study in a small sample
generates the hypothesis that neuroendocrine regulation
differs between obese women with and without BED after
obesity surgery. This finding needs replication in future
studies that should also examine the causal direction of the
observed association.
Keywords Salivarycortisol.Eatingdisorders.Obesity.
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Introduction
Obesity, defined as a body mass index (BMI) ≥30 kg/m
2,
has become a major public health problem in industrialized
countries. Part of obese individuals has binge eating
disorder (BED), recurrent episodes of uncontrolled over-
eating, often involving extremely large amounts of foods,
and feelings of depression, guilt, and disgust about the loss
of control over eating and weight and shape appearance.
Obese individuals with BED exhibit greater psychopathology
and often do less well in weight loss treatment compared to
obese individuals without BED [1].
The stress hormone cortisol may play a role in BED.
Stress is a primary trigger for binge eating [2]. Cortisol is
secreted by the adrenal cortex upon activation of the
hypothalamus pituitary adrenal (HPA) axis in response to
physiological or psychological stress, in particular when the
individual is threatened with loss of control [3]; also, food
intake increases cortisol levels [4]. Repeated HPA axis
stimulation may lead to neurobiological changes that
promote the compulsive nature of overeating [5]. Although
stress, loss of control, and food intake are reasons for
patients with BED to have elevated cortisol levels, the
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ultimately result in relatively low cortisol levels [6–8].
Three previous studies that examined cortisol levels
among obese women with and without BED were charac-
terized by a single measurement of cortisol. One study
found no differences in evening cortisol levels [9]. One
study found no differences in morning cortisol levels [10],
but another study found higher morning cortisol levels
among obese women with BED, but no differences in
daytime cortisol levels [11]. The salivary cortisol response
to awakening has been described as a test of the
susceptibility of the HPA axis to stress. The aim of the
current study was to examine daytime salivary cortisol
levels and the awakening cortisol response (ACR) among
obese women with and without BED using cortisol
assessment at two consecutive days at six time points. All
women in our study had undergone laparoscopic adjustable
gastric banding for severe obesity. Although binge eating
will be more difficult for patients with a gastric band, it is
still possible to eat large quantities of food that easily pass
the gastric band, such as chocolate or ice cream.
Method
Procedure
Fifty females were selected for this study. They were
recruited from a large cross-sectional survey study [12]
from which the data were gathered 16 months before.
Overweight women (n=25) who met the criteria for severe
binge eating, score ≥27 on the binge eating scale (BES)
[13], were matched to overweight women (n=25) without
binge eating problems (BES score ≤17) on demographic
characteristics (age, marital status, and educational level)
and depressive symptoms. Forty-six women agreed to
participate and were visited at home by a research assistant
(VC or CdL). During the visit, the clinical eating disorder
examination (EDE) interview was administered to assess
BED and eating psychopathology [14]. Height, weight, and
the waist and hip circumferences were measured at the end of
the interview. Two women with normal BMI's of 25 kg/m
2
were excluded from the study because they were not
overweight. Nearly all participants were obese (BMI
≥30 kg/m
2); two women had BMIs of 29 kg/m
2.H e n c e ,
we decided to use the term “obese women” instead of
“overweight women” in this article. Participants were given
instructions on cortisol assessments for the next 2 days using
a standardized protocol. Cortisol samples of 37 women were
received (response rate 84%). Cortisol assessments of three
out of 37 participants were incomplete, leaving 34 evaluable
women: 16 obese women with BED and 18 obese women
without BED.
Participants
Table 1 provides an overview of demographic and weight
data. Compared to obese women without BED, obese
women with BED did not differ on demographic character-
istics, medication use influencing the HPA system, and
depression score. Also, the preoperative BMI did not differ
between the groups. After the operation, women without
BED had a significantly lower waist-to-hip ratio (WHR)
compared to women with BED [t(30)=2.3, p<0.05]; the
BMI was marginally significantly lower among the non-
BED participants [t(32)=−1.8, p=0.08].
Measurements
Cortisol Assessment Saliva for cortisol assessments was
collected with small cotton wool swabs (Salivette, Sarstedt
AG&Co.,Numbrecht,Germany)inthereal-lifeenvironment
atsixtimepointsduringtwoconsecutivedays.Salivasamples
were collected at awakening, at 15 and 30 min after
BED (n=16) Non-BED (n=18)
Mean SD Mean SD
Postoperative period (months) 42.6 15.1 46.0 13.1
Age (years) 38.4 7.6 42.7 6.5
Education level
a 3.4 1.9 3.7 1.5
Preoperative BMI (kg/m
2) 46.6 6.3 46.1 5.5
Postoperative BMI (kg/m
2) 40.2 8.2 35.8 6.0
Postoperative waist-to-hip ratio 0.85 0.09 0.92 0.08
Depressive symptoms (BDI) 14.9 9.4 13.1 6.4
Use of oral contraceptives (%) 38 33
Use of other medication influencing the HPA system
b (%) 19 17
Marital status: percent single 28 31
Table 1 Characteristics of
obese women with and without
BED
aAn education level of “1”
reflects primary education; “2”
lower secondary education; “3”,
“4”,and“5”secondary education;
and“6”and “7”tertiaryeducation
bThree women with BED and
three women without BED used
antihypertensive medication;
none of the women used
diabetes medication or
other medication that could
influence the HPA axis
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Participants were instructed to rinse their mouth with water
at each sampling point and to refrain from eating, drinking,
smoking, or brushing their teeth in the 30 min before
sampling. Participants stored the saliva samples in a
refrigerator until, at the end of the 2 days, samples were
sent to Utrecht University where they were kept frozen at
−20°C until analysis with a time-resolved immunoassay with
fluorescence detection, DELFIA [15].
Anthropometric Assessment Height was measured without
shoes, and body weight was determined to the nearest
0.5 kg using two identical weight balances. The BMI was
calculated as the weight in kilograms divided by the square
of height in meters. The waist and hip circumferences were
measured, with the subjects standing, using a 1-cm-wide
measuring tape, and WHR was calculated. According to the
recommendation of the WHO, the waist circumference was
measured as the minimum value between the iliac crest and
the lateral costal margin, whereas hip circumference was
determined as the maximum value over the buttocks.
Eating Disorder Examination Interview Binge eating epi-
sodes and eating disorder psychopathology were assessed
with the EDE interview [14]. Four subscales reflect eating
disorder psychopathology: restraint, eating concern, shape
concern, and weight concern. The items assessing eating
disorder features for the four scales focus on the previous
28 days and are rated on a seven-point format (0 to 6) with
higher scores reflecting greater severity or frequency. All
interviews, except one, were audiotaped and reviewed by
the two research assistants who did the interviews and a
third judge (JKL) for the assessment of binge eating
episodes. All judges were blinded to participants' BES
scores that had been used to select the participants. BED
was defined by the presence of a weekly average of at least
one binge eating episode within the past 3 months [16].
There was a high correspondence between the judges
concerning the presence of binge eating episodes with only
one patient being classified differently.
Statistical Analyses
A common criterion used to decide on the normality of
score distributions in small samples is that the skewness
divided by the standard error of the skewness should be
below standardized scores of 3.29 [17]. According to this
criterion, all variables were normally distributed, except for
the cortisol variable. There were five univariate cortisol
outliers (z>3.29) that were assigned a score that was one
unit larger than the next most extreme score in the
distribution [17]. The score distribution of the resulting
cortisol values was not significantly skewed anymore.
Therefore, it was possible to apply parametric statistics.
The mean values of the cortisol samples over the two
sampling days were used for analyses. Cronbach's alpha of
the cortisol assessments over the 2 days was 0.71.
Repeated-measures analysis was used to examine overall
differences in cortisol level over the six values between
women with and without BED. As a measure of the ACR,
the mean level (ACR level: 0, 15, and 30 min after
awakening) and the increase of the cortisol measurements
as a function of the time (0, 15, and 30 min) after
awakening was calculated: the unstandardized regression
coefficient of the regression equation was used (ACR
slope). Analyses of variance were used to examine women
with and without BED on the ACR and eating disorder
pathology (EDE scores). All analyses were controlled for
BMI as a covariate and were done with SPSS 14.0 for
Windows.
Results
BED and Eating Disorder Psychopathology
Obese women with BED had significantly higher scores
than obese women without BED on shape concern, 2.8±1.5
versus 1.8±1.0, F(1, 31)=4.5, p=0.04, restraint 1.8±1.1
versus 0.6±0.8, F(1, 31)=9.0, p<0.01, and eating concern,
Fig. 1 Mean cortisol concentrations (±SE) across the day of women
with (solid line) and without (dashed line) BED
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they did not differ significantly on weight concern, 2.5±1.6
versus 1.8±1.2, F(1, 31)=1.3, n.s. In terms of effect sizes,
the differences on restraint, eating concern, and shape
concern are large.
BED and Cortisol
Figure 1 displays the cortisol concentrations. Repeated-
measures analysis showed that obese women with BED had
significantly lower total cortisol levels during the day than
obese women without BED, F(1, 31)=5.4, p=0.03. This
effect remained significant after additional adjustment for
WHR or depressive symptoms. There were no significant
differences on the ACR slope, F(1, 31)=1.4, p=0.25, and
ACR levels, F(1, 31)=3.5, p=0.07. Comparison of the total
cortisollevelduringthedayusingtheareaunderthecurve[18]
yielded a large difference between women with (9.0±2.4)
and without (10.9±2.4) BED: the effect size d was 0.8 [19].
Discussion
The present study examined the association between binge
eating and salivary cortisol in obese women after bariatric
surgery. Obese women with BED showed lower overall
cortisol levels compared to obese women without BED,
whereas the cortisol response to awakening was not related
to BED. Before discussing this result, we reflect on the
differences in eating psychopathology between obese
women with and without BED.
Obese women with BED scored significantly higher on
three out offourmeasuresofeatingdisorderpsychopathology
compared to obese women without BED. The scores of our
women with BED were rather similar to the scores of BED
patients that have been previously reported [20]. This
suggests that individuals with a gastric band who have
BED are truly eating disordered patients.
Previous studies that examined cortisol levels among
obese women with and without BED [9–11] were all
characterized by a single measurement of cortisol. Our
study was the first to examine the cortisol concentrations
with repeated measurement across consecutive days. We
observed that the overall cortisol level during the day was
lower for obese women with BED than for obese women
without BED. To be able to judge whether the levels of
women with BED are decreased or the levels of women
without BED are increased, future research should include
reference values of a control population obtained under
similar conditions and analyzed in single run. Our main
finding indicates a difference in neuroendocrine regulation
between obese women with and without BED after obesity
surgery.
The WHR of our non-BED group was higher compared
to the BED group. This finding is remarkable, particularly
considering that the non-BED group had a trend towards a
lower BMI. Our non-BED group had both higher WHR
scores and cortisol levels than our BED group. Visceral
obesity characterized by a high WHR is a main character-
istic of the metabolic syndrome. Glucocorticoid-mediated
visceral obesity induced by depression has been suggested
[21,22]. Though our BED and non-BED groups were rather
similar with respect to depressive symptoms, it may be that
binge eating-related depression is different from nonbinge
eating-related depression. Future prospective research
should examine the hypothesis that higher cortisol levels
may promote abdominal obesity [6] by focusing on the
relation between the presence and absence of BED,
depression, neuroendocrine regulation, and visceral obesity
after obesity surgery.
A major limitation of our study is the small sample size. A
moderate difference in awakening cortisol levels between the
BED and non-BED group was not significant, but the power
was enough to detect a large group difference in total cortisol
levels across the day. Moreover, our study did not answer the
question if the difference in cortisol values reflect a primary
defect or a secondary reaction to long-lasting stress, e.g., of
consuming large amounts of food, or another cause. Finally,
our design did not allow the conclusion that obese women
with BED had reduced cortisol levels or that obese women
without BED had higher cortisol levels because we did not
include a normal weight control group in our study.
In conclusion, the present study in a small sample
generates the hypothesis that neuroendocrine regulation
differs between obese women with and without BED after
obesity surgery. This finding needs replication in future
studies that should also examine the causal direction of the
observed association.
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